Skip to content
Research Article Open access CC BY 4.0

Hematological Parameters and Short Term Clinical Outcome after ST-elevation Myocardial Infarction

Ahmed Mohamed Nemr, Dina A. Maria, Sameh Samir Khalel, Mohamed Elsayed Elsetiha

Cardiology and Angiology: An International Journal · pp. 74–82 · Published 26 May 2022

10.9734/ca/2022/v11i430209

Abstract

Background: ST-Elevation myocardial infarction is a major public health problem and a leading cause of death both in developed and developing countries. The values of hematological biomarkers were evaluated as predictors of in hospital mortality and complications, in patients with acute coronary syndromes (ACS). This study aimed to draw a relationship between different hematological parameters and short-term clinical result in STEMI cases treated by primary percutaneous coronary intervention. Methods: This prospective research involved 100 participants that had a STEMI and were receiving primary PCI and they were subjected to detailed history, general and local examination, resting surface ECG, baseline laboratory tests, reperfusion, transthoracic echocardiogram and follow up of clinical outcome. Results: After STEMI, there was not significantly different between cases with low and high NLR (P <0.4). There was significantly different between cases with low and high NLR after STEMI, low and high MPV [in heart failure, death and rehospitalization] and after STEMI, in diabetic patients and in NLR between low and high MPV groups after STEMI (P < 0.05), there was no significant statistical difference between patients with low and high PDW and after STEMI. LVEF were significant less in participants had MACE (P <0.036). In stepwise multivariate regression analysis of hematological parameters, NLR and MPV were significant predictive factors of MACE (P < 0.05). Conclusions: Hematological and coagulation parameters may be utilized as diagnostic and prognostic indicators. Early risk classification enables doctors to closely monitor and treat high-risk patients, as well as schedule them for regular follow-ups, helping to the reduction of mortality.

Hematological parameters short-term clinical outcome st-elevation myocardial infarction.

References (20)

  1. 1 Cardiovascular disease in Europe: epidemiological update 2016 [DOI]
  2. 2 Cardiovascular disease in Europe 2014: epidemiological update [DOI]
  3. 3 Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis [DOI]
  4. 4 Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk? [DOI]
  5. 5 Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective [DOI]
  6. 6 Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction [DOI]
  7. 7 Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries [DOI]
  8. 8 Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: A meta-analysis of observational studies [DOI]
  9. 9 High platelet volume and increased risk of myocardial infarction: 39 531 participants from the general population [DOI]
  10. 10 Platelet distribution width and the extent of coronary artery disease: Results from a large prospective study [DOI]
  11. 11 Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR) [DOI]
  12. 12 Increased Platelet Distribution Width Is Associated With ST-Segment Elevation Myocardial Infarction and Thrombolysis Failure [DOI]
  13. 13 Increased Platelet Distribution Width Is Associated With Severity of Coronary Artery Disease in Patients With Acute Coronary Syndrome [DOI]
  14. 14 Association of Lymphocyte-to-Monocyte Ratio With the Mortality in Patients With ST-Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention [DOI]
  15. 15 Prognostic value of hematological parameters in patients with acute myocardial infarction: Intrahospital outcomes [DOI]
  16. 16 Prognostic Value of Mean Platelet Volume in Patients With Non-ST-Elevation Acute Coronary Syndrome [DOI]
  17. 17 Neutrophil Lymphocyte Ratio: APrognostic Marker in Acute ST Elevation Myocardial Infarction.
  18. 18 026 TRENDS IN IN-HOSPITAL TREATMENTS, INCLUDING REVASCULARISATION, FOLLOWING ACUTE MYOCARDIAL INFARCTION, 2003–2010: A MULTI-LEVEL AND RELATIVE SURVIVAL ANALYSIS FOR THE NATIONAL INSTITUTE FOR CARDIOVASCULAR OUTCOMES RESEARCH (NICOR) [DOI]
  19. 19 Efficacy of Hematological and Coagulation Parameters in the Diagnosis and Prognosis of Patients with Acute Coronary Syndrome [DOI]
  20. 20 Association of lymphocyte-to-monocyte ratio with the long-term outcome after hospital discharge in patients with ST-elevation myocardial infarction: a retrospective cohort study [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

51

Page views

0

PDF downloads

13

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.